Publications by authors named "G Ben-David"
Article Synopsis
- The study aimed to assess the effectiveness of subconjunctival tranexamic acid (TXA) in reducing bleeding, shortening surgery time, and enhancing recovery in pterygium surgery through a double-blind, randomized controlled trial involving 50 patients.
- Results showed no significant differences between the TXA group and the saline control group in terms of surgery duration, intraoperative bleeding, or postoperative visual acuity, with both groups faring similarly in all main outcome measures.
- Although the use of TXA was deemed safe with no adverse effects, the findings suggest that it does not provide substantial benefits in improving surgical outcomes for pterygium surgery, indicating a need for further research on alternative treatments or surgical techniques.
MicroRNAs as Biomarkers for Uveitis in Juvenile Idiopathic Arthritis.
Ocul Immunol Inflamm
November 2024
Purpose: Uveitis associated with juvenile idiopathic arthritis (JIA-U) is a clinically silent vision-impairing disease. Early detection and aggressive treatment are crucial for optimal visual outcome. Alterations in levels of microRNAs (miRNAs) are characteristic of autoimmune diseases.
View Article and Find Full Text PDFBackground: To better understand and analyze various aspects of scientific publication, bibliometric data analysis is useful.
Objectives: An analysis of the factors associated with shorter publication times in pediatric ophthalmology and strabismus (POS) between the years 2002 and 2007, compared to 2014 and 2018.
Methods: In this retrospective bibliometric analysis, we analyzed 2,487 articles related to POS from the official websites of 8 preselected ophthalmology journals.
Article Synopsis
- 3K3A-Activated Protein C (APC) is a new anticoagulant that offers protective benefits and a lower risk of bleeding, showing promise for treating choroidal neovascularization (CNV), which can lead to vision loss.
- In experiments using a mouse model with laser-induced CNV, 3K3A-APC was injected into the eye, revealing its effects on immune cell activation and inflammatory markers.
- The results showed that 3K3A-APC reduced harmful immune responses and inflammation, leading to a decrease in CNV growth and leakage, suggesting it could be a effective multi-target treatment for this eye condition.
Psychiatric disorders affect millions of individuals and their families worldwide, and the costs to society are substantial and are expected to rise due to a lack of effective treatments. Personalized medicine-customized treatment tailored to the individual-offers a solution. Although most mental diseases are influenced by genetic and environmental factors, finding genetic biomarkers that predict treatment efficacy has been challenging.
View Article and Find Full Text PDF